Aneurysmal Subarachnoid Hemorrhage Drug Market Insights
Overview of the Aneurysmal Subarachnoid Hemorrhage Drug Market The aneurysmal subarachnoid hemorrhage (aSAH) drug market is witnessing significant growth due to the rising prevalence of cerebral aneurysms and the increasing need for effective therapeutic interventions. aSAH is a life-threatening condition caused by bleeding into the space surrounding the brain, often resulting in severe neurological complications. … Read more